Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:52 UTC |
---|
HMDB ID | HMDB0015143 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Busulfan |
---|
Description | Busulfan, also known as busulphano or myleran, belongs to the class of organic compounds known as organosulfonic acid esters. These are esters of sulfonic acid, which have the general structure RS(=O)2OR' (R,R' = organyl, not H). Busulfan is a drug which is used for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia (fda has designated busulfan as an orphan drug for this use). it is also used as a component of pretransplant conditioning regimens in patients undergoing bone marrow transplantation for acute myeloid leukemia and nonmalignant diseases. It is also used as an insect sterilant. Busulfan is possibly neutral. Busulfan is formally rated as a carcinogen (by IARC 1) and is also a potentially toxic compound. A methanesulfonate ester that is butane-1,4-diol in which the hydrogens of the hydroxy groups are replaced by methanesulfonyl groups. An alkylating antineoplastic agent, it is used for the treatment of chronic myeloid leukemia (although it has been largely replaced by newer drugs). |
---|
Structure | CS(=O)(=O)OCCCCOS(C)(=O)=O InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
1,4-Bis(methanesulfonoxy)butane | ChEBI | 1,4-Butanediol dimethanesulfonate | ChEBI | 1,4-Dimesyloxybutane | ChEBI | 1,4-Dimethanesulfonoxybutane | ChEBI | Bisulfex | ChEBI | Busulfano | ChEBI | Busulfanum | ChEBI | Leucosulfan | ChEBI | Mablin | ChEBI | Mielucin | ChEBI | Misulban | ChEBI | Mitostan | ChEBI | Myeloleukon | ChEBI | Myleran | ChEBI | Tetramethylene bis(methanesulfonate) | ChEBI | 1,4-Bis(methanesulphonoxy)butane | Generator | 1,4-Butanediol dimethanesulfonic acid | Generator | 1,4-Butanediol dimethanesulphonate | Generator | 1,4-Butanediol dimethanesulphonic acid | Generator | 1,4-Dimethanesulphonoxybutane | Generator | Bisulphex | Generator | Busulphano | Generator | Busulphanum | Generator | Leucosulphan | Generator | Tetramethylene bis(methanesulfonic acid) | Generator | Tetramethylene bis(methanesulphonate) | Generator | Tetramethylene bis(methanesulphonic acid) | Generator | Busulphan | Generator | Busulphane | HMDB | Butanedioldimethanesulfonate | HMDB | Buzulfan | HMDB | Sulfabutin | HMDB | Sulphabutin | HMDB | Tetramethylene dimethane sulfonate | HMDB | Tetramethylenester kyseliny methansulfonove | HMDB | Busulfan wellcome brand | HMDB | Busulfex | HMDB | Orphan brand OF busulfan | HMDB | Busulfan glaxosmithkline brand | HMDB | Busulfan orphan brand | HMDB | Busulfan wellcome | HMDB | Myelosan | HMDB | Mylecytan | HMDB | Wellcome, busulfan | HMDB | Glaxo wellcome brand OF busulfan | HMDB | Glyzophrol | HMDB | Myléran | HMDB | Wellcome brand OF busulfan | HMDB | GlaxoSmithKline brand OF busulfan | HMDB | N-Butane-1,3-di(methylsulfonate) | HMDB |
|
---|
Chemical Formula | C6H14O6S2 |
---|
Average Molecular Weight | 246.302 |
---|
Monoisotopic Molecular Weight | 246.02317956 |
---|
IUPAC Name | 4-(methanesulfonyloxy)butyl methanesulfonate |
---|
Traditional Name | busulfan |
---|
CAS Registry Number | 55-98-1 |
---|
SMILES | CS(=O)(=O)OCCCCOS(C)(=O)=O |
---|
InChI Identifier | InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3 |
---|
InChI Key | COVZYZSDYWQREU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as organosulfonic acid esters. These are esters of sulfonic acid, which have the general structure RS(=O)2OR' (R,R' = organyl, not H). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Organic sulfonic acids and derivatives |
---|
Sub Class | Organosulfonic acids and derivatives |
---|
Direct Parent | Organosulfonic acid esters |
---|
Alternative Parents | |
---|
Substituents | - Organosulfonic acid ester
- Sulfonic acid ester
- Sulfonyl
- Methanesulfonate
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organosulfur compound
- Organooxygen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 287 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 5.16 g/L | Not Available | LogP | -0.3 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Busulfan GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a6r-4910000000-e9ddf91161b812713ab4 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Busulfan GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Busulfan LC-ESI-qTof , Positive-QTOF | splash10-014i-1490000000-7895468c598e6a0480c8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Busulfan LC-ESI-qTof , Positive-QTOF | splash10-014i-0390000000-19a6e15d2bf397b244b1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Busulfan , positive-QTOF | splash10-014i-0390000000-19a6e15d2bf397b244b1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Busulfan , positive-QTOF | splash10-014i-1490000000-7895468c598e6a0480c8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 10V, Positive-QTOF | splash10-0002-0290000000-d4b566ed54a53c849786 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 20V, Positive-QTOF | splash10-0udi-3910000000-3801100c88a8c43def33 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 40V, Positive-QTOF | splash10-004r-9500000000-3dec1d870a9203efd37f | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 10V, Negative-QTOF | splash10-0002-3090000000-aa607731139624cbe5bc | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 20V, Negative-QTOF | splash10-004i-9110000000-7405cd0ebfa01ce907a0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 40V, Negative-QTOF | splash10-004i-9000000000-4e28fa66f6cebb7272cc | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 10V, Positive-QTOF | splash10-0uka-9530000000-c112640ccc30da208327 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 20V, Positive-QTOF | splash10-0a4j-9000000000-ed8101663b60977229ec | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 40V, Positive-QTOF | splash10-0a4i-9000000000-4f0ac4d1c58f92828a43 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 10V, Negative-QTOF | splash10-0002-0090000000-1d2d39d4577a3e5e71ad | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 20V, Negative-QTOF | splash10-000j-2960000000-3752c572e539716a5e2e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Busulfan 40V, Negative-QTOF | splash10-002f-9100000000-644c96579ffd326045dc | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01008 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01008 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01008 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 2384 |
---|
KEGG Compound ID | C06862 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Busulfan |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 2478 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 28901 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Hall AG, Tilby MJ: Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Blood Rev. 1992 Sep;6(3):163-73. [PubMed:1422285 ]
- Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA: Platelet-derived serotonin mediates liver regeneration. Science. 2006 Apr 7;312(5770):104-7. [PubMed:16601191 ]
- Nath CE, Shaw PJ: Busulphan in blood and marrow transplantation: dose, route, frequency and role of therapeutic drug monitoring. Curr Clin Pharmacol. 2007 Jan;2(1):75-91. [PubMed:18690856 ]
- Krivoy N, Hoffer E, Lurie Y, Bentur Y, Rowe JM: Busulfan use in hematopoietic stem cell transplantation: pharmacology, dose adjustment, safety and efficacy in adults and children. Curr Drug Saf. 2008 Jan;3(1):60-6. [PubMed:18690982 ]
- Ciurea SO, Andersson BS: Busulfan in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009 May;15(5):523-36. doi: 10.1016/j.bbmt.2008.12.489. Epub 2009 Feb 12. [PubMed:19361744 ]
- McCune JS, Holmberg LA: Busulfan in hematopoietic stem cell transplant setting. Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):957-69. doi: 10.1517/17425250903107764. [PubMed:19611402 ]
- Valdez BC, Andersson BS: Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies. Environ Mol Mutagen. 2010 Jul;51(6):659-68. doi: 10.1002/em.20603. [PubMed:20577993 ]
- (). FDA label . .
|
---|